In severe juvenile-onset recurrent respiratory papillomatosis of a 10-year-old, systemic bevacizumab is highly effective and well tolerated

Details

ISSN :

14393824

Database :

OpenAIRE

Journal :

Klinische Pädiatrie

Accession number :

edsair.doi...........2e8d1dd2b398904b344a952831d1dfe1